LPL Financial LLC increased its position in Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) by 66.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 87,446 shares of the company’s stock after purchasing an additional 35,053 shares during the period. LPL Financial LLC owned 0.22% of Phibro Animal Health worth $1,836,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Quantbot Technologies LP boosted its holdings in shares of Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company’s stock valued at $107,000 after acquiring an additional 2,018 shares in the last quarter. New York State Teachers Retirement System grew its holdings in Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares during the last quarter. Amundi increased its position in shares of Phibro Animal Health by 185.5% in the fourth quarter. Amundi now owns 9,855 shares of the company’s stock valued at $212,000 after buying an additional 6,403 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after purchasing an additional 906 shares in the last quarter. Finally, Ieq Capital LLC acquired a new position in shares of Phibro Animal Health in the fourth quarter worth $302,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages have weighed in on PAHC. Barclays boosted their price target on Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a report on Monday, February 10th. Morgan Stanley upped their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, StockNews.com cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to MarketBeat, Phibro Animal Health has an average rating of “Hold” and a consensus price target of $21.00.
Phibro Animal Health Stock Down 6.1 %
PAHC stock opened at $16.81 on Wednesday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The firm has a fifty day moving average price of $21.95 and a two-hundred day moving average price of $22.39. Phibro Animal Health Co. has a 1-year low of $12.30 and a 1-year high of $26.55. The firm has a market cap of $680.97 million, a price-to-earnings ratio of 35.02, a PEG ratio of 0.45 and a beta of 0.63.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Research analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.86%. Phibro Animal Health’s dividend payout ratio (DPR) is 100.00%.
Phibro Animal Health Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories
- Five stocks we like better than Phibro Animal Health
- How to Read Stock Charts for Beginners
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- How Technical Indicators Can Help You Find Oversold Stocks
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.